Boehringer Ingelheim and 3T Biosciences to develop next-generation cancer immunotherapies
Boehringer Ingelheim and 3T Biosciences have entered into a strategic collaboration and licensing agreement to…
January 9, 2023 - 2 minutes
Boehringer Ingelheim
Psoriasis pustules disappear in over half of patients using Boehringer Ingelheim drug
More than half of patients treated for psoriasis with an intravenous injection showed no visible…
September 2, 2022 - 2 minutes
Three companies join forces to tackle antimicrobial resistance (AMR)
A joint venture to create the next generation of antimicrobials, along with actionable diagnostics to…
July 7, 2022 - 4 minutes
How Will We Be Treating Cystic Fibrosis 10 Years From Now?
Current treatments for cystic fibrosis are not suitable for all patients and have a limited…
November 22, 2021 - 9 minutes
ADC Approval Buoys Spirits in Cancer Treatment Space
The FDA recently approved an antibody-drug conjugate drug from ADC Therapeutics as a treatment for…
May 11, 2021 - 7 minutes
Boehringer Ingelheim Acquires Cancer Vaccine Biotech in €325M Deal
The German giant Boehringer Ingelheim has acquired the Swiss company AMAL Therapeutics and its cancer…
July 16, 2019 - 2 minutes
Boehringer Ingelheim Acquires Oncolytic Virus Biotech Company
Boehringer Ingelheim is paying €210M to acquire all the remaining shares of ViraTherapeutics, an Austrian…
September 13, 2018 - 2 minutes
Boehringer Offers €1Bn for New Checkpoint Inhibitor from a French Biotech
OSE Immunotherapeutics could receive up to €1.1Bn from its new partner Boehringer Ingelheim, which has…
April 5, 2018 - 2 minutes
No Nonsense Boehringer Ingelheim Jettisons Failing Alzheimer’s Disease Drug
Boehringer Ingelheim has ditched its Alzheimer's drug after it failed to meet the endpoints of…
February 12, 2018 - 3 minutes
Boehringer Ingelheim Doubles its Venture Fund for Exciting Biotech
Boehringer Ingelheim has committed to continue helping young companies grow by doubling the size of…
January 4, 2018 - 2 minutes
Schizophrenia and Drug Delivery Biotechs Sign a Major Pharma Partner
Santa Claus is not the only busy one in the weeks leading up to Christmas…
December 19, 2017 - 2 minutes
German Pharma and Biotech Gang Up on NASH in an Exciting Collaboration
Boehringer Ingelheim's fight against liver disease is taking shape, having agreed on a partnership with…
November 8, 2017 - 3 minutes
